Support for the NEOMED Institute for the implementation of an innovation and commercialization complex
MONTRÉAL, Dec. 7, 2018 - The City of Montréal and the Government of Canada announced today their financial support for the NEOMED Institute for the implementation of a new innovation and commercialization complex (ICC), specializing in life sciences and health technology (LSHT). This complex will provide SMEs with customized labs, shared equi
Read complete news
NEOMED Institute Announces the Appointment of Dr. Youssef Bennani to its Board of Directors
Montreal, Quebec, November 14, 2018 – NEOMED Institute announced today that experienced bio-pharmaceutical scientist and executive Dr. Youssef Bennani has joined its Board of Directors.
Dr. Youssef Bennani is currently Chairman of the Board of Domain Therapeutics (France & Canada), and is an independent Board member of
Read complete news
Ampersand Invests in Management Buyout of Clinical Immunology Provider NEOMED-LABS from the NEOMED Institute
LAVAL, QC. and WELLESLEY, MA., September 4, 2018 – Ampersand Capital Partners, together with the management team of NEOMED-LABS and the NEOMED Institute, announced today that Ampersand has partnered with management in the acquisition of NEOMED-LABS from its not-for-profit founder and parent, the NEOMED Institute.
NEOMED-LABS i
Read complete news
The NEOMED Institute is proud to be a Gold Sponsor of the 8th BioConnect Symposium jointly organized with the International Biotechnology Symposium (IBS2018)
The NEOMED Institute is pleased to announce its partnership with the BioConnect symposium, which will take place on August 16, 2018, as part of the International Biotechnology Symposium and Exhibition (IBS2018), at the Palais des congrès de Montréal (Montreal Convention Centre).
Montreal (QC), June 28, 2018
Read complete news
